Skip to content
Governance Register

← US public companies

Y-Mabs Therapeutics, Inc.

SEC CIK 1722964 · YMAB · last insider filing 2025-09-19

Directors (from insider filings)

NameCapacity as filedFilings
Hamill Laura Director filed 2020 - 2025
Gill David N Director filed 2018 - 2025
Healy James Director filed 2018 - 2025
Tyagi Ashu Director filed 2018 - 2025
Wedell-Wedellsborg Johan Director filed 2018 - 2025
WG Biotech ApS Director filed 2018 - 2025
Gad Thomas Director · See remarks filed 2018 - 2025
Rossi Michael J Director · President and CEO filed 2023 - 2025
Tagliaferri Mary Director filed 2024 - 2024
Ber Gerard Director filed 2018 - 2024
Kruse Bo Director · EVP, CFO, Secy & Treas. filed 2018 - 2024
Moller-San Pedro Claus Juan Director · Director and CEO filed 2018 - 2021
Raskin Gregory S Director filed 2018 - 2019
Buschle Michael Director filed 2018 - 2018

Officers (from insider filings)

NameTitle as filedFilings
Pfreundschuh Peter P. EVP, CFO and Treasurer filed 2024 - 2025
Larocca John SVP, General Counsel & Secry filed 2025 - 2025
Wilms Joris Sr. VP and COO filed 2018 - 2025
Gentilcore Douglas J SVP, Danyelza Bus. Unit Head filed 2025 - 2025
Lund-Hansen Torben Sr. VP and Head of Tech Op filed 2018 - 2024
Rajah Vignesh SVP and CMO filed 2020 - 2024
Smith Susan Laura Senior Vice President, CCO filed 2021 - 2024
Lisby Steen Sr. VP and CMO filed 2018 - 2024
Herman Philip Karl Sr. VP and CCO filed 2020 - 2020
Ahmed Mahiuddin Sr. VP and CSO filed 2020 - 2020

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.